🧪
ASO-mediated reduction of toxic C9orf72 dipeptide repeat proteins in ALS/FTD
active
hypothesis
Created: 2026-05-01T10:21:23
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: h-c56d4f6a1a
🧪 Hypothesis Details
Composite Score76%proposed
Confidence
88%
Novelty
65%
Feasibility
72%
Impact
82%
Antisense oligonucleotides targeting expanded GGGGCC repeats in C9orf72 offer the strongest therapeutic hypothesis by simultaneously addressing three pathogenic mechanisms: C9orf72 haploinsufficiency, RNA foci sequestration, and toxic dipeptide repeat protein accumulation. The tofersen precedent validates the ASO modality for motor neuron disease, and ongoing clinical trials (NCT03626012) provide immediate translational momentum. Critical risks include cortical delivery limitations for FTD patho...
Metadata
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.